Georgia Erbez - 22 Sep 2021 Form 4 Insider Report for Harpoon Therapeutics, Inc.

Role
Chief Financial Officer
Signature
/s/ Georgia Erbez by Christopher Whitmore, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
22 Sep 2021
Net transactions value
+$83,430
Form type
4
Filing time
22 Sep 2021, 21:30:44 UTC
Previous filing
03 Jun 2021
Next filing
15 Nov 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HARP Common Stock Purchase $83,430 +10,300 +116% $8.10* 19,215 22 Sep 2021 By IRA F1
holding HARP Common Stock 6,700 22 Sep 2021 See footnote F2
holding HARP Common Stock 72,292 22 Sep 2021 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares indirectly held by Georgia Leigh Erbez Charles Schwab & Co Inc Cust IRA Contributory ("Georgia Erbez IRA Contributory"). The Reporting Person has beneficial ownership over these shares held by Georgia Erbez IRA Contributory.
F2 Shares indirectly held by David Milan Erbez Charles Schwab & Co Inc Cust IRA Contributory ("David Erbez IRA Contributory"). The Reporting Person has beneficial ownership over these shares held by David Erbez IRA Contributory.